Compile Data Set for Download or QSAR
Report error Found 82 Enz. Inhib. hit(s) with all data for entry = 11247
TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM50459091(ABL-001 | ABL001 | ABL001-NX | Asciminib | NVP-ABL...)
Affinity DataIC50: 16nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM50237710(AMN 107 | AMN107 | 4-methyl-N-[3-(4-methyl-1H-imid...)
Affinity DataIC50: 33nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602606(US11649218, Example NCGC00508975)
Affinity DataIC50: 48nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602609(US11649218, Example NCGC00507975)
Affinity DataIC50: 83nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602536(US11649218, Example NCGC00483140)
Affinity DataIC50: 105nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602608(US11649218, Example NCGC00508838)
Affinity DataIC50: 105nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602612(US11649218, Example NCGC00508972)
Affinity DataIC50: 112nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602537(US11649218, Example NCGC00481508)
Affinity DataIC50: 118nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602611(US11649218, Example NCGC00532289)
Affinity DataIC50: 118nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602538(US11649218, Example NCGC00411866)
Affinity DataIC50: 166nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602539(US11649218, Example NCGC00355551)
Affinity DataIC50: 187nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602540(US11649218, Example NCGC00481504)
Affinity DataIC50: 235nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602541(US11649218, Example NCGC00482446)
Affinity DataIC50: 264nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602542(US11649218, Example NCGC00356665)
Affinity DataIC50: 296nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602607(US11649218, Example NCGC00508973)
Affinity DataIC50: 398nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602543(US11649218, Example NCGC00481503)
Affinity DataIC50: 526nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM13530(cid_5291 | STI571 | N-(4-methyl-3-{[4-(pyridin-3-y...)
Affinity DataIC50: 631nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602544(US11649218, Example NCGC00355558)
Affinity DataIC50: 743nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602546(US11649218, Example NCGC00411876)
Affinity DataIC50: 833nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602545(US11649218, Example NCGC00373056)
Affinity DataIC50: 833nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM50328152(N-(2-hydroxyethyl)-3-(6-(4-(trifluoromethoxy)pheny...)
Affinity DataIC50: 935nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM50325999(3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-...)
Affinity DataIC50: 935nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602547(US11649218, Example NCGC00373057)
Affinity DataIC50: 935nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602548(US11649218, Example NCGC00356666)
Affinity DataIC50: 935nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602549(US11649218, Example NCGC00355552)
Affinity DataIC50: 1.05E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602550(US11649218, Example NCGC00388536)
Affinity DataIC50: 1.05E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602551(US11649218, Example NCGC00373058)
Affinity DataIC50: 1.18E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602552(US11649218, Example NCGC00409812)
Affinity DataIC50: 1.18E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602553(US11649218, Example NCGC00411874)
Affinity DataIC50: 1.18E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602604(US11649218, Example NCGC00532318)
Affinity DataIC50: 1.28E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602554(US11649218, Example NCGC00482456)
Affinity DataIC50: 1.48E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602605(US11649218, Example NCGC00507969)
Affinity DataIC50: 1.55E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602555(US11649218, Example NCGC00481507)
Affinity DataIC50: 1.66E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602556(US11649218, Example NCGC00356745)
Affinity DataIC50: 1.87E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602557(US11649218, Example NCGC00373064)
Affinity DataIC50: 1.87E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602558(US11649218, Example NCGC00388557)
Affinity DataIC50: 2.09E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602559(US11649218, Example NCGC00355556)
Affinity DataIC50: 2.35E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602560(US11649218, Example NCGC00373062)
Affinity DataIC50: 2.64E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602561(US11649218, Example NCGC00387293)
Affinity DataIC50: 2.96E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602562(US11649218, Example NCGC00387294)
Affinity DataIC50: 2.96E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602563(US11649218, Example NCGC00415019)
Affinity DataIC50: 3.32E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602564(US11649218, Example NCGC00373060)
Affinity DataIC50: 3.32E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602565(US11649218, Example NCGC00388580)
Affinity DataIC50: 3.32E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602566(US11649218, Example NCGC00388560)
Affinity DataIC50: 3.72E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602567(US11649218, Example NCGC00371309)
Affinity DataIC50: 3.72E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602570(US11649218, Example NCGC00371644)
Affinity DataIC50: 4.18E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602568(US11649218, Example NCGC00371364)
Affinity DataIC50: 4.18E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602569(US11649218, Example NCGC00373061)
Affinity DataIC50: 4.18E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602571(US11649218, Example NCGC00355569)
Affinity DataIC50: 4.69E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ABL1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM602572(US11649218, Example NCGC00373063)
Affinity DataIC50: 4.69E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 82 total ) | Next | Last >>
Jump to: